AstraZeneca Lifts Profit Target
Stock quotes in this article:
AZN
Pfizer successfully defended a major Lipitor patent in the U.K. recently, but a Pfizer defeat in the U.S. will have a ripple effect on the entire market, Purcell says. If Pfizer loses, Crestor's U.S. market share could stall, hurting AstraZeneca's long-term EPS estimates by 5% or 6%.
Purcell doesn't own shares, but his firm plans to receive or seek investment-banking compensation from AstraZeneca in the next three months.- Loading Comments...
- Loading Comments...
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,270.47 | 1,093.48 | 2,167.88 | 34.29 |
Oil *
75.55
|
|
UP
73.00
|
UP
6.24
|
UP
18.86
|
DOWN
0.17
|
10 Yr
3.43%
SPDR Gold
109.74
|
|
+0.72%
|
+0.57%
|
+0.88%
|
-0.49%
|
Data delayed 20 minutes |
